In an agreement with Cinven and Novo Holdings, EQT X (EQT Private Equity) and Mubadala Investment Company (Mubadala) have agreed to acquire Envirotainer (the Company), a leading global provider of temperature-controlled supply chain solutions for the transportation of biopharmaceuticals. It has an enterprise value of approximately €2.8 billion.
Globally, millions of people rely on the safe delivery of biopharmaceuticals that need temperature control to maintain their integrity and quality. Chronic diseases resulting from changing diets and lifestyles, pollution, and lack of access to medicines are factors causing distress to underserved communities today. With its climate-neutral cold chain solutions, Envirotainer expands access to pharmaceuticals and vaccines that are safe, reliable, and efficient for patients.
By accelerating expansion in APAC and sustaining stable growth in other core markets, EQT Private Equity and Mubadala will support Envirotainer in its next phase of growth. To accomplish this, they will use EQT’s local-with-locals approach and Mubadala’s global network. CryoSure’s two investors will help scale its newly launched CryoSure offering and further the successful rollout of third-generation Releye containers while investing in new technologies, digitalisation, and sustainability.
Envirotainer was founded in Stockholm in 1985. Its headquarters, R&D and production facilities are located there. Envirotainer produces and leases active temperature-controlled containers primarily used for air freighting biopharma products. The company operates a global fleet of approximately 6,700 containers and employs approximately 375 people in twenty countries. Over 600 companies worldwide use its services, including blue-chip global pharmaceutical companies.